Blue Diamond Ventures Inc (BLDV)

[JPS02]

stervc, I think the following paragraph in your post is very powerful and insightful, therefore I broke up each sentence to better understand each of the important points you are presenting:

stervc's post: http://investorshub.advfn.com/boards/read_msg.aspx?message_id=132570308

1. AMS will pay the Funder back the $12 million plus interest from the Revenues to be generated.

2. AMS already have relationships with pharmaceutical companies as clientele in place to support their marijuana cultivation in Canada whom will buy product and products from AMS.

3. They also have huge plans for expansion in place.

4. After a year and since the AMS project is expected to be fully operational by then, AMS is then expected to exercise its right to refinance its operations by using their completed facility as collateral to remove the current Funder from the equation.

5. They will pay the Funder back its money with interest then AMS will become their own Funder by funding its own operations.

These important points that you present beg the question of the value of AMS to BLDV once the:

i) $12 million financing is approved;

ii) Health Canada approval to cultivate is received;

iii) Revenues start to be earned from cultivation operations; and,

iv) Expansion is completed in the future.

I think this question is important in regards to the positive impact on the BLDV pps given the non-dilutive acquisition of AMS that you pointed out in this post:

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=132347362

Thanks for sharing your insightful thoughts.

Go BLDV!